CDH6 as a prognostic indicator and marker for chemotherapy in gliomas

Glioma is the most malignant cancer of the central nervous system. There are various therapies for treating gliomas, but their outcomes are not satisfactory. Therefore, new targets for glioma treatment are needed. This study examined the cadherin-6 (CDH6) expression in gliomas using The Cancer Genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Ming, Zhou, Hongshu, He, Ye, Chen, Lu, Wang, Wanpeng, Yang, Liting, Wang, Zeyu, Zhang, Liyang, Wang, Sha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355303/
https://www.ncbi.nlm.nih.gov/pubmed/35938030
http://dx.doi.org/10.3389/fgene.2022.949552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355303/
https://www.ncbi.nlm.nih.gov/pubmed/35938030
http://dx.doi.org/10.3389/fgene.2022.949552

Ejemplares similares